Late complications of port-a-cath in oncology and hematology patients

Authors

  • Ana Claudia da Silva de Andrade UPF
  • Ana Carolina Piacini HOSPITAL DE CLINICAS DE PASSO FUNDO
  • Roberto Lenz UNIVERSIDADE DE PASSO FUNDO
  • Thaís Dresch Eberhardt UNIVERSIDADE DE PASSO FUNDO

DOI:

https://doi.org/10.36704/cipraxis.v20i35.9276

Keywords:

Vascular Access Devices , Oncology, Nursing

Abstract

Introduction: The port-a-cath catheter is a fully implanted device that facilitates venous access in oncology patients, especially those requiring prolonged chemotherapy or compromised venous networks.

Objective: To identify the incidence of immediate and late complications related to the implantation of the port-a-cath central venous catheter.

Methods: This is a quantitative, descriptive, and longitudinal study conducted in a large hospital in the interior of Rio Grande do Sul. Data were collected through printed questionnaires applied to oncology and hematology patients undergoing catheter implantation, as well as data available in the electronic medical records. The data were analyzed using descriptive statistics. The project was approved by the Research Ethics Committee, with assessment number 6.594.762 and Certificate of Presentation for Ethical Consideration No. 69297023.1.0000.5342. All participants signed the Informed Consent Form (ICF).

Results: Of the 31 participants included in the study, the majority were female, with a mean age of 57.0 years. The most common oncological diagnoses were lymphomas (41.9%), followed by breast neoplasms (22.6%). The incidence of immediate complications was 61.3%, and late complications were 6.5%, with edema (35.5%) and hematoma (35.5%) being the most frequently occurring immediate complications, while local pain (6.5%) was the most common late complication.

Conclusion: A high incidence of immediate complications was identified, particularly edema and hematoma, whereas late complications had a lower incidence. However, local pain persisted throughout the entire follow-up period (six months).

References

AMERICAN

CANCER

SOCIETY.

Non-Hodgkin

https://www.cancer.org/cancer/non-hodgkin-lymphoma.html

lymphoma,

2020.

BAILLEUL, Amaury et al. Risk factors and prognostic significance of infection of totally implantable

vascular access port in solid tumor patients: A prospective cohort study. Infectious Diseases Now,

v. 53, n. 8, p. 104766, 2023.

BRASIL. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa de 2023 - Incidência de

Câncer no Brasil. Rio de Janeiro, dez. 2022.

BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Resolução n° 466, de 12 de dezembro

de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos.

Diário Oficial da União, Brasília, DF, 13 jun. 2013, Seção 1, p. 59.

CARDOSO Aline Mendes et al. Construção e validação de cartilha educativa para pacientes

oncológicos acerca do cateter venoso central totalmente implantável. Revista Eletrônica Acervo

Saúde, v. 23, n. 5, p. e11992, 2023.

CARDOSO, Anna Maria Garcia et al. Portocath insertion technique: retrospective study & step-by

step surgical description without tunneling in a high-complexity service. Revista do Colégio

Brasileiro de Cirurgiões, v. 49, p. e20223167, 2022. Disponível em: https://doi.org/10.1590/0100

6991e-20223167.

CÉSAR, Rodrigo Melo; LAGE, Ana P. Drummond; WAINSTEIN, Alberto. Follow up of utility and value

of totally implantable chemotherapy catheter in 233 brazilian patients receiving chemotherapy to

treat cancer. Revista do Colégio Brasileiro de Cirurgiões, v. 50, 2023. Disponível em:

https://doi.org/10.1590/0100-6991e-20233367.

CHANDVEETTIL, Jashma et al. Totally implantable venous access devices in cancer chemotherapy:

A retrospective analysis of 8421 catheter days in a tertiary cancer center. Cancer Research,

Statistics, and Treatment, v. 4, n.3, p. 449-55, 2021.

CHANG, Tung-Cheng; YEN, Min-Hsuein; KIU, Kee-Thai. Incidence and risk factor for infection of

totally implantable venous access port. Langenbeck's Archives of Surgery, v. 407, n. 1, p. 343-51,

2022. doi: 10.1007/s00423-021-02328-0.

D'SOUZA, Philomena C et al. Complications and Management of Totally Implantable Central

Venous Access Ports in Cancer Patients at a University Hospital in Oman. Sultan Qaboos

University Medical Journal, v. 21, n. 1, p. e103-e109, 2021. doi: 10.18295/squmj.2021.21.01.014.

FONSECA, Deborah Franscielle da et al. Protocolo de cuidados com cateter venoso totalmente

implantado: uma construção coletiva. Texto & Contexto Enfermagem, v. 28, p. e20180352, 2019.

Disponível em: http://dx.doi.org/10.1590/1980-265X-TCE-2018-0352.

GUAN, Xiaonan et al. Risk factors of infection of totally implantable venous access port: A

retrospective study. The Journal of Vascular Access, v. 24, n. 6, p. 1340-8, 2023.

KAUR, Rasanpreet; BHARDWAJ, Alok; GUPTA, Saurabh. Cancer treatment therapies: traditional to

modern approaches to combat cancers. Molecular Biology Reports, v. 50, n. 11, p. 9663-9676,

2023. doi: 10.1007/s11033-023-08809-3.

KIM, Jung Tae et al. Clinical review and analysis of complications of totally implantable venous acess

devices for chemoteraphy, Medical Oncology, v. 19, p. 1361-1364, 2012.

LOAIZA, Katty Paulina Cabrera et al. Lifestyle and breast cancer: review article. Mastology, v. 33, p.

e20230014,

2023.

Disponível

content/uploads/2023/03/MAS_2023014_AOP-1.pdf

em:

https://www.mastology.org/wp

MARINO, Pasquale et al. Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent

Cancer. Nutrients, v. 16, n. 6, p. 800, 2024. Disponível em: https://doi.org/10.3390/nu16060800

PEIXOTO, Rafaela Martins de Almeida et al. Complicações do cateter port a cath: subsídios para os

cuidados de enfermagem: Revista Enfermagem Atual In Derme, v. 87, n. 25, 2019. Disponível em: https://revistaenfermagematual.com.br/index.php/revista/article/view/169.

PINELLI, Fulvio et al. Infection of totally implantable venous access devices: A review of the

literature. The Journal of Vascular Access, v. 19, n. 13, 2018.

TSURUTA, Shigeaki et al. Late complications associated with totally implantable venous access port

implantation via the internal jugular vein. Supportive Care in Cancer, v. 28, n. 6, p. 2761-2768,

2020.

TUMAY, Latif Volkan; GUNER, Osman Serhat. Availability of totally implantable venous access

devices in cancer patients is high in the long term: a seven-year follow-up study. Support Care in

Cancer, v 29, n. 7, p. 3531-3538, 2021. https://doi.org/10.1007/s00520-020-05871-6.

VORPAGEL, Kalinka Moraes et al. Implementação de procedimento operacional padrão sobre o

manejo do cateter venoso central totalmente implantado em serviço de oncologia. Enfermagem

Brasil, v. 21, n. 6, p. 726-39, 2022.

WORLD HEALTH ORGANIZATION (WHO). Cancer fact sheets, 2021. https://www.who.int/news

room/fact-sheets/detail/cancer

WU, Olivia et al. Venous access devices for the delivery of long-term chemotherapy: the CAVA

three-arm RCT. Health Technology Assessment, v. 25, n. 47, p. 1-126, 2021. doi:

10.3310/hta25470.

YILDIRIM, Nadide Örs. Totally Implantable Venous Access Devices: Study of 1,613 Patients and

Complication Management. Journal of The Cardiovascular Thoracic Anaesthesia and Intensive

Care Society, v. 29, n. 4, p. 211-7, 2023.

Published

2025-06-13

How to Cite

da Silva de Andrade, A. C., Piacini, A. C., Lenz, R., & Eberhardt , T. D. (2025). Late complications of port-a-cath in oncology and hematology patients. Ciência Et Praxis, 20(35), 302–314. https://doi.org/10.36704/cipraxis.v20i35.9276